M&A Deal Summary

FMC Acquires GAT Microencapsulation

On December 1, 2012, FMC acquired life science company GAT Microencapsulation from PONTIS Capital

Acquisition Highlights
  • This is FMC’s 1st transaction in the Life Science sector.
  • This is FMC’s 1st transaction in Austria.

M&A Deal Summary

Date 2012-12-01
Target GAT Microencapsulation
Sector Life Science
Buyer(s) FMC
Sellers(s) PONTIS Capital
Deal Type Add-on Acquisition

Target

GAT Microencapsulation

Ebenfurth, Austria
GAT Microencapsulation is a recognized microencapsulation specialist focusing on the stabilization of sensitive active ingredients in the fields of plant protection. GAT Microencapsulation is based in Ebenfurth, Austria.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

FMC

Philadelphia, Pennsylvania, United States

Category Company
Founded 1883
Sector Chemicals
Employees5,700
Revenue 4.2B USD (2024)
DESCRIPTION

FMC is an American chemical manufacturing company. It is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. FMC was incorporated in 1883 and is based in Philadelphia, Pennsylvania.


DEAL STATS #
Overall 5 of 9
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Austria M&A 1 of 1
Year: 2012 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-01 Pectine Italia

Milan, Italy

Pectine Italia S.p.A. an Italian based manufacturer of pectin for the food ingredients market. Pectine Italia produces pectin, a well known stabilizer and thickening agent used widely in many foods and derived predominately from lemon peels.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-24 Epax AS

Oslo, Norway

Epax is a manufacturer of bulk marine Omega-3 oils for use in dietary supplements and functional foods. Epax was the former industrial brands division of Pronova Biocare and this divison was demerged from Pronova in December 2005.

Buy $345M

Seller(S) 1

SELLER

PONTIS Capital

Vienna, Austria

Investor


Category Growth Capital Firm
Founded 2005
PE ASSETS 90M EUR
Size Small
Type Sector Focused
DESCRIPTION

PONTIS Capital is a private investment group focused on high-growth tech businesses in Central Europe. PONTIS looks to invest €1 to €5 million in businesses generating €2 to €40 million in sales. PONTIS seeks companies with experienced management, 'proof of market', and 'scalable business models that can be applied internationally'. Sectors of interest include information/communication technologies, clean technology, and life sciences. PONTIS was formed in 2005 and is based in Vienna.


DEAL STATS #
Overall 5 of 8
Sector: Life Science M&A 2 of 3
Type: Add-on Acquisition M&A Deals 3 of 6
Country: Austria M&A 4 of 6
Year: 2012 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-01 evidanza

Straubing, Germany

evidanzaas is a software company that develops its own business intelligence solutions based on Microsoft technologies. evidanza was founded in 2004 and is based in Straubing, Germany.

Buy €4M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-12 Lixto Software

Vienna, Austria

Lixto provides innovative search technology delivering structured results from Web queries. Both businesses and consumers use Lixto technology to derive more relevant and better structured results from the Web than normal search engines provide. Lixto delivers solutions in the area of metasearch, online market intelligence and Web process integration.

Sell -